Search

Author/Creator Cerva, C.

1. A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases. (February 2019)

Authors:
Salpini, R.; Cerva, C.; Battisti, A.; Piermatteo, L.; Sacco, A.; Malagnino, V.; Arcese, W.; Cantonetti, M.; Ceccherini-Silberstein, F.; Perno, C.F.; Andreoni, M.; Sarmati, L.; Svicher, V.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: A real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort. (10th February 2016)

Authors:
Colombatto, P.; Biliotti, E.; Palazzo, D.; Ciancio, A.; Del Pin, B.; Rizzo, V.; Brancaccio, G.; Pasetto, M.C.; Castelli, E.; Ieluzzi, D.; Franceschet, E.; Storato, S.; Margotti, M.; Castelli, E.; Palladini, S.; Amoruso, D.C.; Buggio, A.; Madonia, S.; Cerva, C.; Bartolozzi, D.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Full‐Genome Sequence of Porcine Circovirus type 3 recovered from serum of sows with stillbirths in Brazil. Issue 1 (12th October 2017)

Authors:
Tochetto, C.; Lima, D. A.; Varela, A. P. M.; Loiko, M. R.; Paim, W. P.; Scheffer, C. M.; Herpich, J. I.; Cerva, C.; Schmitd, C.; Cibulski, S. P.; Santos, A. C.; Mayer, F. Q.; Roehe, P. M.
Journal:
Transboundary and emerging diseases
Issue:
Volume 65:Issue 1(2018)
Page Start:
5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016)

Authors:
Battisti, A.; Salpini, R.; Colagrossi, L.; Alteri, C.; Pollicita, M.; Ricciardi, A.; Cerva, C.; Maffongelli, G.; Lichtner, M.; Mastroianni, C.; Casinelli, K.; Paoloni, M.; Marignani, M.; Maylin, S.; Delaugerre, C.; Morisco, F.; Coppola, N.; Marrone, A.; Brega, A.; Francioso, S.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. In HBeAg-negative chronic HBV infection, HBsAg levels profoundly differ among HBV-genotypes and can be affected by the extent of HBsAg variability: Can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?. Issue 1 (16th February 2017)

Authors:
Salpini, R.; Battisti, A.; Anastasiou, O.; Gill, U.; Colagrossi, L.; Bertoli, A.; Fabeni, L.; Fini, V.; Piermatteo, L.; Iuvara, A.; Malagnino, V.; Cerva, C.; Lichtner, M.; Mastroianni, C.; De Sanctis, G.; Paoloni, M.; Marignani, M.; Pasquazzi, C.; Iapadre, N.; Mari, T.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Key mutations in HBsAg C-terminus correlate with lower HBsAg levels in vivo, hinder HBsAg release in vitro and affect HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection. (February 2019)

Authors:
Piermatteo, L.; Battisti, A.; Carioti, L.; Anastasiou, O.; Gill, U.S.; Colagrossi, L.; Bertoli, A.; Aragri, M.; Iuvara, A.; Malagnino, V.; Cerva, C.; Lichtner, M.; Mastroianni, C.M.; De Sanctis, G.M.; Maurizio, P.; Marignani, M.; Pasquazzi, C.; Iapadre, N.; Mari, T.; Parruti, G.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. (November 2016)

Authors:
Cerva, C.; Colagrossi, L.; Maffongelli, G.; Salpini, R.; Di Carlo, D.; Malagnino, V.; Battisti, A.; Ricciardi, A.; Pollicita, M.; Bianchi, A.; Picardi, A.; Cudillo, L.; Cerretti, R.; De Angelis, G.; Cantonetti, M.; Andreoni, M.; Perno, C.F.; Arcese, W.; Svicher, V.; Sarmati, L.
Journal:
Clinical microbiology and infection
Issue:
Volume 22:Number 11(2016)
Page Start:
946.e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗